Entrepreneurial minded executive leader with 30 years of operational experience in MedTech. Has been a key driver in building shareholder value with both large and small start-up medical device companies. Prior to joining Cardio Flow, Inc., Scott was the Zone General Manager with Abiomed, where he was responsible for expanding product adoption of the Impella® percutaneous LVAD system, which was acquired by Johnson & Johnson for $16.6B.Previous to this, he worked for a series of start-ups: Cardiovascular Systems, Inc. (CSI acquired by Abbott), Intact Vascular (acquired by Philips), and Intersect ENT (acquired by Medtronic), where he gained strategic and tactical experience launching and driving product launches of disruptive technologies in newly created markets, ranging from orbital atherectomy systems and drug-eluting stents to implantable cardiac rhythm management devices.Most notably, Scott joined CSI as a Product Manager and moved to Germany, where he worked with key opinion leaders to gain knowledge and preparation for designing and developing the Go-to-Market (GTM) strategy in the US. He subsequently served as VP of Sales at CSI (acquired by Abbott for $780 million), where he helped build and lead a 100-person commercial organization that generated $80 million in annual revenue. Scott was instrumental in driving strategic and tactical plans for commercial execution that resulted in achieving market leadership. At Intact Vascular, he held the role of VP of Sales and Market Development, where he worked closely with the CEO to raise a $15M Series A round of venture funding, which was utilized to fund the OUS post-market TOBA study in Europe, paving the path for the U.S. regulatory strategy.Scott has worked for a combination of commercial and clinical-stage companies over the course of his career, and his scope of influence spans commercial, operations, business development, market development, and close collaboration with clinical, regulatory, and quality teams.Earlier in Scott’s career he worked at Boston Scientific, C.R. Bard, and Guidant in the coronary, cardiac rhythm management, peripheral, and vascular surgery markets, gaining experience in creating new markets and driving the adoption of new technologies and procedures. Scott holds a B.S. in Finance from Villanova University and an M.B.A. from Saint Joseph’s University.